Trial Profile
Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Aug 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine; Fluorouracil; Folinic acid; Levamisole; Oxaliplatin
- Indications Colorectal cancer; Liver metastases
- Focus Therapeutic Use
- 24 Jan 2013 New trial record